Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-20

Clinical Trial Update: Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis [NA]

View source ↗

Summary

A completed clinical trial evaluating TNF-alpha inhibitor therapy in TNF-alpha–naive patients with poor-prognosis rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Manitoba | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED